These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15468379)

  • 21. Chronic overdose of leflunomide inducing interstitial nephritis.
    Haydar AA; Hujairi N; Kirkham B; Hangartner R; Goldsmith DJ
    Nephrol Dial Transplant; 2004 May; 19(5):1334-5. PubMed ID: 15102985
    [No Abstract]   [Full Text] [Related]  

  • 22. Serious liver disease in a patient receiving methotrexate and leflunomide.
    Weinblatt ME; Dixon JA; Falchuk KR
    Arthritis Rheum; 2000 Nov; 43(11):2609-11. PubMed ID: 11083289
    [No Abstract]   [Full Text] [Related]  

  • 23. Rheumatoid arthritis and the Arava (leflunomide) controversy.
    Turkoski BB
    Orthop Nurs; 2003; 22(1):48-51. PubMed ID: 12640952
    [No Abstract]   [Full Text] [Related]  

  • 24. Leflunomide-induced aseptic meningitis.
    Cohen JD; Jorgensen C; Sany J
    Joint Bone Spine; 2004 May; 71(3):243-5. PubMed ID: 15182800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment with leflunomide in rheumatoid arthritis].
    Krüger K; Bolten W
    Z Rheumatol; 2005 Mar; 64(2):96-101. PubMed ID: 15793675
    [No Abstract]   [Full Text] [Related]  

  • 26. Is there a place for leflunomide in the treatment of rheumatoid arthritis?
    Breedveld FC
    Lancet; 2001 Oct; 358(9289):1198-200. PubMed ID: 11675052
    [No Abstract]   [Full Text] [Related]  

  • 27. Leflunomide in treatment of rheumatoid arthritis.
    McCarey DW; Capell HA; Madhok R
    Lancet; 2002 Mar; 359(9312):1158. PubMed ID: 11943298
    [No Abstract]   [Full Text] [Related]  

  • 28. Leflunomide-associated skin ulceration.
    McCoy CM
    Ann Pharmacother; 2002 Jun; 36(6):1009-11. PubMed ID: 12022903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leflunomide induced vasculitis--a dose-response relationship.
    Chan AT; Bradlow A; McNally J
    Rheumatology (Oxford); 2003 Mar; 42(3):492-3. PubMed ID: 12626811
    [No Abstract]   [Full Text] [Related]  

  • 30. [Leflunomide: a new treatment for an old disease].
    Monteagudo Sáez I; López Longo FJ; González Fernández CM; Carreño Pérez L
    Rev Clin Esp; 2000 May; 200 Monog 1():114-8. PubMed ID: 10901036
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis.
    Silverman E; Spiegel L; Hawkins D; Petty R; Goldsmith D; Schanberg L; Duffy C; Howard P; Strand V
    Arthritis Rheum; 2005 Feb; 52(2):554-62. PubMed ID: 15693001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leflunomide for the treatment of rheumatoid arthritis and autoimmunity.
    Sanders S; Harisdangkul V
    Am J Med Sci; 2002 Apr; 323(4):190-3. PubMed ID: 12003373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary aspergillosis in chronic leflunomide treatment.
    Tomos P; Lachanas E; Agathos EA; Grigorakos L
    Surg Infect (Larchmt); 2012 Aug; 13(4):282-3. PubMed ID: 22958096
    [No Abstract]   [Full Text] [Related]  

  • 34. [Leflunomide-induced toxic epidermal necrolysis].
    El Aïdli S; Salouage I; Kastalli S; Srairi S; Daghfous R; Loueslati MH; Belkahia C
    Therapie; 2008; 63(2):157-8. PubMed ID: 18677817
    [No Abstract]   [Full Text] [Related]  

  • 35. [Leflunomide in the treatment of rheumatoid arthritis].
    Kochbati S; Ben Miled M; Boussema F; Ktari S; Daoud L; Ben Rhouma S; Ben Amor G; Chérif O; Rokbani L
    Tunis Med; 2005 Feb; 83(2):91-7. PubMed ID: 15969231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subacute cutaneous lupus erythematosus associated with leflunomide.
    Elias AR; Tam CC; David-Bajar KM
    Cutis; 2005 Sep; 76(3):189-92. PubMed ID: 16268263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of leflunomide on the peripheral nerves in rheumatoid arthritis.
    Richards BL; Spies J; McGill N; Richards GW; Vaile J; Bleasel JF; Youssef PP
    Intern Med J; 2007 Feb; 37(2):101-7. PubMed ID: 17229252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leflunomide: new indication. In psoriatic rheumatism: too many risks, too little efficacy.
    Prescrire Int; 2005 Aug; 14(78):123-6. PubMed ID: 16106593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photodistributed lichenoid drug eruption with rhabdomyolysis occurring during leflunomide therapy.
    Rivarola de Gutierrez E; Abaca H
    Dermatology; 2004; 208(3):232-3. PubMed ID: 15118375
    [No Abstract]   [Full Text] [Related]  

  • 40. Photodistributed eruption with rhabdomyolisis due to leflunomide.
    Adamski H; Lopez L; Polard E; Chevrant-Breton J; Dupuy A
    Photodermatol Photoimmunol Photomed; 2011 Aug; 27(4):222-3. PubMed ID: 21729173
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.